Related Experiment Video

Updated: Jun 1, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Review of diphtheria, tetanus and pertussis vaccines in clinical development

Nicholas R E Kitchin1

  • 1Pfizer Ltd, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK. nicholas.kitchin@pfizer.com

Expert Review of Vaccines
|May 25, 2011
PubMed

Insights

Diphtheria, tetanus, and pertussis vaccines are crucial for child immunization. Current research focuses on combining more vaccines and offering early pertussis protection.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatric Infectious Diseases

Background:

  • Diphtheria, tetanus, and pertussis (DTaP) vaccines are foundational childhood immunizations.
  • Historically, DTaP vaccines used inactivated whole-cell pertussis components.
  • Recent advancements include purified acellular pertussis vaccines with better safety profiles.

Purpose of the Study:

  • To review the evolution of DTaP vaccines.
  • To highlight the development of combination vaccines.
  • To discuss strategies for early pertussis immunization.

Main Methods:

  • Literature review of DTaP vaccine development.
  • Analysis of advancements in vaccine formulation.
  • Examination of strategies for pre-infant immunization.

Main Results:

  • Acellular pertussis vaccines show improved reactogenicity.
  • Combination vaccines (DTaP with Hib, HepB, IPV) are increasingly common.
  • Focus on early pertussis protection strategies is ongoing.

Conclusions:

  • DTaP vaccines have significantly evolved from whole-cell to acellular formulations.
  • Combination vaccines enhance immunization efficiency and coverage.
  • Future directions aim for broader vaccine combinations and earlier pertussis immunity.

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Related Concept Videos

Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...